Home » Topics » BioWorld Science

BioWorld Science
RSS

Beta2-integrins as potential targets for ANCA-mediated glomerulonephritis

Nov. 10, 2021

IL-33, a potential new therapeutic target for diabetic kidney disease

Nov. 10, 2021

NN-1213 lowers appetite and body weight in animal models of obesity

Nov. 10, 2021

Researchers identify markers of adrenomyeloneuropathy severity

Nov. 10, 2021

New mouse model allows investigation of EP3 receptor function in the kidney tubule

Nov. 10, 2021

Verve announces preclinical data on GalNAc-LNP technology to deliver ANGPTL3 base editor in NHPs

Nov. 9, 2021

Cybin reports positive preclinical data on deuterated psilocybin analogue

Nov. 9, 2021

PDS Biotechnology licenses rights to proprietary TARP antigen from NCI

Nov. 9, 2021

MC4 receptor induces antipsychotic drug-related metabolic syndrome

Nov. 9, 2021

Cocrystal Pharma reports pan-viral activity of SARS-CoV-2 main protease inhibitors

Nov. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...